The psychedelic drugs market is emerging as a strategic investment opportunity in healthcare, with forecasts generally placing its value around US$6.4 billion in 2025. This burgeoning sector is set for robust, double-digit compound annual growth, significantly driven by North America, which is anticipated to account for approximately 45–50 percent of…
Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) (‘Homerun’ or the ‘Company’) is pleased to announce that Strand Hanson Limited…
The US Federal Reserve held its fifth meeting of 2025 from Tuesday (July 29) to Wednesday (July 30) against…
The uranium market entered Q2 on shaky footing, with spot prices slipping to around US$63.50 per pound (March 13)—the…
Sranan Gold (CSE:SRAN,FSE:P84) is a junior exploration company focused on Suriname, a South American country that produces over 600,000…
From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working…
As the global push toward electrification accelerates, lithium remains a critical piece of the energy transition. Continued oversupply remained…